These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 29361459

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of prophylactic dalteparin on anti-factor Xa levels in morbidly obese patients after bariatric surgery.
    Simoneau MD, Vachon A, Picard F.
    Obes Surg; 2010 Apr; 20(4):487-91. PubMed ID: 18931882
    [Abstract] [Full Text] [Related]

  • 3. Assessment of empiric body mass index-based thromboprophylactic dosing of enoxaparin after bariatric surgery: evidence for dosage adjustment using anti-factor Xa in high-risk patients.
    Karas LA, Nor Hanipah Z, Cetin D, Schauer PR, Brethauer SA, Daigle CR, Aminian A.
    Surg Obes Relat Dis; 2021 Jan; 17(1):153-160. PubMed ID: 33046419
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A Single-Center Comparison of Extended and Restricted THROMBOPROPHYLAXIS with LMWH after Metabolic Surgery.
    Leeman M, Biter LU, Apers JA, Birnie E, Verbrugge S, Verhoef C, Dunkelgrun M.
    Obes Surg; 2020 Feb; 30(2):553-559. PubMed ID: 31641983
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV, Howes J, Sharma V, Kadziola Z.
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [Abstract] [Full Text] [Related]

  • 10. Lean body weight is the best scale for venous thromboprophylaxis algorithm in severely obese patients undergoing bariatric surgery.
    Gaborit B, Moulin PA, Bege T, Boullu S, Vincentelli C, Emungania O, Morange PE, Berdah S, Salem JE, Dutour A, Frere C.
    Pharmacol Res; 2018 May; 131():211-217. PubMed ID: 29452290
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Perioperative thromboprophylaxis in severely obese patients undergoing bariatric surgery: insights from a French national survey.
    Moulin PA, Dutour A, Ancel P, Morange PE, Bege T, Ziegler O, Berdah S, Frère C, Gaborit B.
    Surg Obes Relat Dis; 2017 Feb; 13(2):320-326. PubMed ID: 27720420
    [Abstract] [Full Text] [Related]

  • 13. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery.
    Birkmeyer NJ, Finks JF, Carlin AM, Chengelis DL, Krause KR, Hawasli AA, Genaw JA, English WJ, Schram JL, Birkmeyer JD, Michigan Bariatric Surgery Collaborative.
    Arch Surg; 2012 Nov; 147(11):994-8. PubMed ID: 23165612
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis.
    Wagner J, Wruck H, Lautenbach A, von Kroge P, Wolter S, Mann O, Izbicki J, Duprée A.
    Obes Surg; 2022 Mar; 32(3):861-867. PubMed ID: 34988894
    [Abstract] [Full Text] [Related]

  • 15. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
    Steele KE, Canner J, Prokopowicz G, Verde F, Beselman A, Wyse R, Chen J, Streiff M, Magnuson T, Lidor A, Schweitzer M.
    Surg Obes Relat Dis; 2015 Mar; 11(3):672-83. PubMed ID: 25620436
    [Abstract] [Full Text] [Related]

  • 16. Prophylaxis of thromboembolism in bariatric surgery with parnaparin.
    Forestieri P, Quarto G, De Caterina M, Cuocolo A, Pilone V, Formato A, Ruocco A, Ferrari P.
    Obes Surg; 2007 Dec; 17(12):1558-62. PubMed ID: 18004632
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL, Altimiras J, Larruzea I, Gómez-Outes A, Martínez-González J, Rocha E, Bemiparin Cooperative Study Group in Surgery for Cancer.
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.